You have 9 free searches left this month | for more free features.

apalutamide

Showing 1 - 25 of 123

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Apalutamide
  • +2 more
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)

Not yet recruiting
  • Prostate Cancer With ≤10 Bone Metastases
  • Apalutamide
  • +2 more
  • (no location specified)
Feb 22, 2023

Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Sep 6, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • Beijing, China
  • +3 more
Jan 17, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Apalutamide 60mg Tab
  • Androgen deprivation therapy(ADT)
  • Nanjing, Jiangsu, China
  • +2 more
Mar 17, 2023

Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Castration-Sensitive Prostate Cancer
  • apalutamide
  • +3 more
  • Shanghai, Shanghai, China
  • +1 more
Feb 4, 2023

Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

Not yet recruiting
  • Metastatic Castrate-sensitive Prostate Cancer
  • Apalutamide
  • Androgen-deprivation Therapy (ADT)
  • Lakewood, Colorado
  • +5 more
May 23, 2023

Prostatic Tumors Trial in Worldwide (EPI-7386, Abiraterone Acetate, Prednisone or Prednisolone)

Suspended
  • Prostatic Neoplasms
  • Towson, Maryland
  • +3 more
Nov 3, 2022

Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

Not yet recruiting
  • Oligometastatic Hormone Sensitive Prostate Cancer
  • SBRT on all sites of metastatic disease+Apalutamide
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jan 29, 2023

Apalutamide in Metastatic Hormone Sensitive Prostate Cancer

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • Cardiff, United Kingdom
    • +4 more
    Aug 25, 2023

    Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

    Active, not recruiting
    • Prostate Cancer
    • Apalutamide
    • +3 more
    • Omaha, Nebraska
    • +4 more
    Nov 10, 2022

    Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

    Not yet recruiting
    • Metastatic Cancer
    • Neoplasm, Prostate
    • Abiraterone acetate
    • +2 more
    • Bronx, New York
      James J. Peters VA Medical Center
    Jun 16, 2022

    Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

    Completed
    • Prostate Cancer
    • Leuprolide acetate
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    May 25, 2022

    Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

    Active, not recruiting
    • Castration-Resistant Prostate Cancer
    • Apalutamide
    • Greenville, South Carolina
    • +4 more
    Aug 2, 2022

    Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

    Recruiting
    • Small Cell Neuroendocrine Carcinoma
    • +2 more
    • Apalutamide
    • Cetrelimab
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

    Completed
    • Prostate Adenocarcinoma
    • +4 more
    • Abiraterone Acetate
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Milano, Milan (APA + ADT, Local Treatmetn RT or RP)

    Not yet recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • APA + ADT
    • Local Treatmetn RT or RP
    • Milano, Lombardia, Italy
    • +2 more
    Jan 17, 2023

    Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

    Terminated
    • Prostate Adenocarcinoma
    • Apalutamide
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 28, 2021

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Apalutamide
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 20, 2023

    Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

    Recruiting
    • Prostate Cancer
    • Boston, Massachusetts
    • +5 more
    Jul 14, 2022

    Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

    Recruiting
    • Localized Prostate Carcinoma
    • +8 more
    • Apalutamide
    • Quality-of-Life Assessment
    • Tucson, Arizona
    • +4 more
    Jun 28, 2022

    Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

    Not yet recruiting
    • Prostate Cancer
    • Apalutamide Oral Product
    • +2 more
    • Cincinnati, Ohio
      University of Cincinnati Medical Center
    Mar 27, 2023

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

    Suspended
    • Castration-Resistant Prostate Carcinoma
    • +4 more
    • Abiraterone Acetate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 27, 2022

    Learn About Novel Hormonal Therapies for Metastatic

    Not yet recruiting
    • Prostatic Neoplasms
    • Novel hormonal therapy
    • New York, New York
      Pfizer Inc
    Nov 21, 2023